LYRA vs ROP · rev $1.5M vs P/E 41, rev $4.20B
Lyra Therapeutics Inc (LYRA) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
LYRA currently screens at market cap $14.4M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the LYRA and ROP stock pages for the full models.
Not investment advice.